Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigens-Reference-Cited by-同舟云学术

Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigens

Published:1998-03 Issue:3 Volume:52 Page:253-270
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Jelı́nková M,Strohalm J,Plocová D,Šubr V,Št'astný M,Ulbrich K,Řı́hová B

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference60 articles.

1. Immunotoxins: Hybrid molecules combining high specificity and potent cytotoxicity;Jansen;Immunol. Rev.,1982

2. The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation;Vitetta;Transplantation,1984

3. Immunotoxins;Pastan;Cell,1986

4. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support;Press;N. Engl. J. Med.,1993

5. Retention of B-cell specific monoclonal antibodies by human lymphoma cells;Press;Blood,1994

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPMA copolymer-antibody constructs in neoplastic treatment: an overview of therapeutics, targeted diagnostics, and drug-free systems;Journal of Controlled Release;2020-09

2. Targeted Delivery of Recombinant Heat Shock Protein 27 to Cardiomyocytes Promotes Recovery from Myocardial Infarction;Molecular Pharmaceutics;2020-05-04

3. Recent Progress of Doxorubicin Nanomedicine in Hematologic Malignancies;Nanoscience and Nanotechnology Letters;2017-12-01

4. HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release;Macromolecular Bioscience;2017-08-14

5. A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas;European Journal of Pharmaceutical Sciences;2017-05